| 000 | 01738 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513091156.0 | ||
| 264 | 0 | _c19960715 | |
| 008 | 199607s 0 0 eng d | ||
| 022 | _a0022-5223 | ||
| 024 | 7 |
_a10.1016/s0022-5223(96)70227-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRaikar, G V | |
| 245 | 0 | 0 |
_aNitric oxide inhibition attenuates systemic hypotension produced by protamine. _h[electronic resource] |
| 260 |
_bThe Journal of thoracic and cardiovascular surgery _cJun 1996 |
||
| 300 |
_a1240-6; discussion 1246-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiac Output _xdrug effects |
| 650 | 0 | 4 |
_aCyclic GMP _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 |
_aHeparin _xpharmacology |
| 650 | 0 | 4 |
_aHypotension _xchemically induced |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylene Blue _xpharmacology |
| 650 | 0 | 4 | _aModels, Cardiovascular |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtamines _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aomega-N-Methylarginine |
| 700 | 1 | _aHisamochi, K | |
| 700 | 1 | _aRaikar, B L | |
| 700 | 1 | _aSchaff, H V | |
| 773 | 0 |
_tThe Journal of thoracic and cardiovascular surgery _gvol. 111 _gno. 6 _gp. 1240-6; discussion 1246-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0022-5223(96)70227-1 _zAvailable from publisher's website |
| 999 |
_c8641862 _d8641862 |
||